{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:52:02Z","timestamp":1788367922632,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1R44TR004234-01"],"award-info":[{"award-number":["1R44TR004234-01"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.slasd.2025.100248","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T21:51:36Z","timestamp":1752616296000},"page":"100248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A scalable human gut-immune co-culture model for evaluating inflammatory bowel disease anti-inflammatory therapies"],"prefix":"10.1016","volume":"35","author":[{"given":"Swetha","family":"Peddibhotla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Boone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earnest L.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9000-6614","authenticated-orcid":false,"given":"Bryan E.","family":"McQueen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0368-2572","authenticated-orcid":false,"given":"Elizabeth M.","family":"Boazak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.slasd.2025.100248_bib0029","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.chc.2010.01.007","article-title":"Inflammatory bowel disease","volume":"19","author":"Szigethy","year":"2010","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"1","key":"10.1016\/j.slasd.2025.100248_bib0014","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00384-024-04711-x","article-title":"Global, regional, and national burden of inflammatory bowel disease, 1990-2021: insights from the global burden of disease 2021","volume":"39","author":"Lin","year":"2024","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.slasd.2025.100248_bib0006","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7247238","article-title":"A comprehensive review and update on the pathogenesis of inflammatory bowel disease","volume":"2019","author":"Guan","year":"2019","journal-title":"J Immunol Res"},{"issue":"8","key":"10.1016\/j.slasd.2025.100248_bib0025","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.cgh.2020.10.038","article-title":"Efficacy and safety of extended induction with Tofacitinib for the treatment of ulcerative colitis","volume":"20","author":"Sandborn","year":"2022","journal-title":"Clin Gastroenterol Hepato: Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"3","key":"10.1016\/j.slasd.2025.100248_bib0009","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s44164-022-00017-w","article-title":"In vitro models and ex vivo systems used in inflammatory bowel disease","volume":"1","author":"Joshi","year":"2022","journal-title":"Vitro Models"},{"key":"10.1016\/j.slasd.2025.100248_bib0002","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1525s104","article-title":"Dextran sulfate sodium (DSS)-induced colitis in mice","volume":"104","author":"Chassaing","year":"2014","journal-title":"Curr Protoc Immunol."},{"issue":"33","key":"10.1016\/j.slasd.2025.100248_bib0003","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.3748\/wjg.v23.i33.6016","article-title":"Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis","volume":"23","author":"Eichele","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.slasd.2025.100248_bib0030","unstructured":"Treuting, P.M., Dintzis, S.M., Frevert, C.W., Liggitt, D., & Montine, K.S. (2012). Comparative anatomy and histology: a mouse and Human atlas (Expert Consult). Academic Press."},{"issue":"5","key":"10.1016\/j.slasd.2025.100248_bib0016","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J Immunol (Baltimore, Md.: 1950)"},{"issue":"8","key":"10.1016\/j.slasd.2025.100248_bib0023","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/embor.2012.96","article-title":"Innate immune signalling at the intestinal epithelium in homeostasis and disease","volume":"13","author":"Pott","year":"2012","journal-title":"EMBO Rep"},{"issue":"10\u201311","key":"10.1016\/j.slasd.2025.100248_bib0013","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/00498250701704819","article-title":"Intestinal permeability and its relevance for absorption and elimination","volume":"37","author":"Lennern\u00e4s","year":"2007","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.slasd.2025.100248_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell Biol Toxicol"},{"issue":"4","key":"10.1016\/j.slasd.2025.100248_bib0028","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/17425255.4.4.395","article-title":"The Caco-2 cell monolayer: usefulness and limitations","volume":"4","author":"Sun","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"10.1016\/j.slasd.2025.100248_bib0031","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/gutjnl-2013-306651","article-title":"Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays","volume":"64","author":"VanDussen","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.slasd.2025.100248_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-74802-w","article-title":"Comparison of iPSC-derived human intestinal epithelial cells with Caco-2 cells and human in vivo data after exposure to lactiplantibacillus plantarum WCFS1","volume":"14","author":"Janssen","year":"2024","journal-title":"Sci Rep"},{"issue":"Pt 1","key":"10.1016\/j.slasd.2025.100248_bib0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tiv.2017.08.011","article-title":"Development of an in vitro co-culture model to mimic the human intestine in healthy and diseased state","volume":"45","author":"K\u00e4mpfer","year":"2017","journal-title":"Toxicol Vitro: An Int J Publish Assoc BIBRA"},{"issue":"2","key":"10.1016\/j.slasd.2025.100248_bib0001","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.4110\/in.2020.20.e13","article-title":"Microphysiological engineering of immune responses in intestinal inflammation","volume":"20","author":"Ambrosini","year":"2020","journal-title":"Immune Netw"},{"issue":"8","key":"10.1016\/j.slasd.2025.100248_bib0012","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.3390\/ijms24087427","article-title":"Development of an inflammation-triggered In vitro \u201cleaky gut\u201d model using Caco-2\/HT29-MTX-E12 combined with macrophage-like THP-1 cells or primary Human-derived macrophages","volume":"24","author":"Le","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"31","key":"10.1016\/j.slasd.2025.100248_bib0015","article-title":"Recent advances in cell-based In Vitro models to recreate Human intestinal inflammation","volume":"10","author":"Macedo","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"10.1016\/j.slasd.2025.100248_bib0027","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/0118715230294413240415054610","article-title":"Decades long involvement of THP-1 cells as a model for macrophage research: a comprehensive review","volume":"23","author":"Sharma","year":"2024","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"issue":"11","key":"10.1016\/j.slasd.2025.100248_bib0004","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/intimm\/5.11.1383","article-title":"Induction of IFN-gamma in macrophages by lipopolysaccharide","volume":"5","author":"Fultz","year":"1993","journal-title":"Int Immunol"},{"issue":"8","key":"10.1016\/j.slasd.2025.100248_bib0007","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3390\/ijms20082023","article-title":"TET1 Knockdown inhibits Porphyromonas gingivalis LPS\/IFN-\u03b3-induced M1 macrophage polarization through the NF-\u03bab pathway in THP-1 cells","volume":"20","author":"Huang","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.slasd.2025.100248_bib0033","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11481-024-10115-z","article-title":"JAK1\/2 Regulates synergy between interferon gamma and lipopolysaccharides in microglia","volume":"19","author":"Young","year":"2024","journal-title":"J Neuroimmune Pharmacol: Off J Soc NeuroImmune Pharmacol"},{"key":"10.1016\/j.slasd.2025.100248_bib0022","article-title":"Characterization and optimization of variability in a human colonic epithelium culture model","author":"Pike","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.slasd.2025.100248_bib0032","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biomaterials.2017.03.005","article-title":"A microengineered collagen scaffold for generating a polarized crypt-villus architecture of human small intestinal epithelium","volume":"128","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.slasd.2025.100248_bib0026","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.yexcr.2006.08.018","article-title":"Induction by activated macrophage-like THP-1 cells of apoptotic and necrotic cell death in intestinal epithelial Caco-2 monolayers via tumor necrosis factor-alpha","volume":"312","author":"Satsu","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.slasd.2025.100248_bib0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12885-015-1546-9","article-title":"M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide","volume":"15","author":"Genin","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.slasd.2025.100248_bib0018","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.taap.2017.09.006","article-title":"Current nonclinical testing paradigm enables safe entry to first-In-Human clinical trials: the IQ consortium nonclinical to clinical translational database","volume":"334","author":"Monticello","year":"2017","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.slasd.2025.100248_bib0019","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul Toxicol Pharmacol: RTP"},{"key":"10.1016\/j.slasd.2025.100248_bib0020","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","article-title":"Macrophage polarization: different gene signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively activated macrophages","volume":"10","author":"Orecchioni","year":"2019","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.slasd.2025.100248_bib0021","first-page":"1394","article-title":"Macrophage polarization and reprogramming in acute inflammation: a redox perspective","volume":"11","author":"P\u00e9rez","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.slasd.2025.100248_bib0017","first-page":"49","article-title":"The relation between the level of interleukin-23 with duration and severity of ulcerative colitis","volume":"5","author":"Mirsattari","year":"2012","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"3 Pt A","key":"10.1016\/j.slasd.2025.100248_bib0011","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jid.2021.07.180","article-title":"Tofacitinib suppresses IL-10\/IL-10R signaling and modulates host defense responses in Human macrophages","volume":"142","author":"Knoke","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.slasd.2025.100248_bib34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/gastroent15030048","article-title":"Mucosal immunity and trained innate immunity of the gut","volume":"15","author":"Velikova","year":"2024","journal-title":"Gastroenterol Insights"},{"key":"10.1016\/j.slasd.2025.100248_bib35","first-page":"299","article-title":"Importance of innate mucosal immunity and the promises it holds","volume":"4","author":"Dwivedy","year":"2011","journal-title":"Int J Gen Med"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555225000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555225000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:32:10Z","timestamp":1779867130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555225000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"alternative-id":["S2472555225000413"],"URL":"https:\/\/doi.org\/10.1016\/j.slasd.2025.100248","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A scalable human gut-immune co-culture model for evaluating inflammatory bowel disease anti-inflammatory therapies","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slasd.2025.100248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Altis Biosystems, Inc. Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100248"}}